AR127892A1 - Compuestos y composiciones para la administración de agentes terapéuticos - Google Patents
Compuestos y composiciones para la administración de agentes terapéuticosInfo
- Publication number
- AR127892A1 AR127892A1 ARP220103357A ARP220103357A AR127892A1 AR 127892 A1 AR127892 A1 AR 127892A1 AR P220103357 A ARP220103357 A AR P220103357A AR P220103357 A ARP220103357 A AR P220103357A AR 127892 A1 AR127892 A1 AR 127892A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- group
- alkenyl
- independently selected
- carbocycle
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 5
- 239000003814 drug Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 9
- 229910052739 hydrogen Inorganic materials 0.000 abstract 9
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 8
- 125000000623 heterocyclic group Chemical group 0.000 abstract 8
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 7
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 5
- 125000006592 (C2-C3) alkenyl group Chemical group 0.000 abstract 5
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 4
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 3
- 125000005842 heteroatom Chemical group 0.000 abstract 3
- 125000004043 oxo group Chemical group O=* 0.000 abstract 3
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 abstract 2
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 abstract 2
- 101100439665 Arabidopsis thaliana SWI2 gene Proteins 0.000 abstract 2
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 102100039788 GTPase NRas Human genes 0.000 abstract 1
- 101000744505 Homo sapiens GTPase NRas Proteins 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 125000002877 alkyl aryl group Chemical group 0.000 abstract 1
- 150000001450 anions Chemical class 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- -1 cationic lipid Chemical class 0.000 abstract 1
- 125000001072 heteroaryl group Chemical group 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
- A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers comprising non-phosphatidyl surfactants as bilayer-forming substances, e.g. cationic lipids or non-phosphatidyl liposomes coated or grafted with polymers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Nanotechnology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cephalosporin Compounds (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163288317P | 2021-12-10 | 2021-12-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR127892A1 true AR127892A1 (es) | 2024-03-06 |
Family
ID=85076438
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP220103357A AR127892A1 (es) | 2021-12-10 | 2022-12-07 | Compuestos y composiciones para la administración de agentes terapéuticos |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250144036A1 (https=) |
| EP (1) | EP4444692A1 (https=) |
| JP (1) | JP2025502627A (https=) |
| CN (1) | CN118369308A (https=) |
| AR (1) | AR127892A1 (https=) |
| TW (1) | TW202333708A (https=) |
| WO (1) | WO2023107669A1 (https=) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4286012A3 (en) | 2015-09-17 | 2024-05-29 | ModernaTX, Inc. | Compounds and compositions for intracellular delivery of therapeutic agents |
| HUE057877T2 (hu) | 2015-12-22 | 2022-06-28 | Modernatx Inc | Vegyületek és készítmények terápiás szerek intracelluláris bejuttatására |
| WO2018170322A1 (en) | 2017-03-15 | 2018-09-20 | Modernatx, Inc. | Crystal forms of amino lipids |
| SMT202300097T1 (it) | 2017-03-15 | 2023-05-12 | Modernatx Inc | Composto e composizioni per il rilascio intracellulare di agenti terapeutici |
| AU2020350759A1 (en) | 2019-09-19 | 2022-03-31 | Modernatx, Inc. | Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents |
| CN116969850A (zh) * | 2022-06-14 | 2023-10-31 | 苏州科锐迈德生物医药科技有限公司 | 碳酸酯-羧酸酯型脂质化合物及基于其的脂质载体、核酸脂质纳米粒组合物和药物制剂 |
| WO2024067639A1 (zh) * | 2022-09-30 | 2024-04-04 | 荣灿生物医药技术(上海)有限公司 | 一种转染效率高的可电离脂质化合物及其应用 |
| CN116947669B (zh) * | 2022-09-30 | 2024-04-12 | 荣灿生物医药技术(上海)有限公司 | 一种转染效率高的可电离脂质化合物及其应用 |
| EP4727914A1 (en) * | 2023-06-14 | 2026-04-22 | ModernaTX, Inc. | Compounds and compositions for delivery of therapeutic agents |
| CN121463960A (zh) * | 2023-06-28 | 2026-02-03 | 上海瑞宏迪医药有限公司 | 一种含有阳离子脂质的药物组合物及其用途 |
| CN121889371A (zh) * | 2023-07-03 | 2026-04-17 | 科纳勒生物公司 | 脂质及其组合物 |
| CN116891423B (zh) * | 2023-07-07 | 2024-03-01 | 荣灿生物医药技术(上海)有限公司 | 脂质化合物、组合物及其制备方法和应用 |
| CN121532376A (zh) * | 2023-07-19 | 2026-02-13 | 正基基因科技有限公司 | 脂质和脂质纳米颗粒 |
| CN119330848B (zh) * | 2023-10-19 | 2025-07-08 | 仁景(苏州)生物科技有限公司 | 用于递送的脂质化合物及脂质纳米颗粒 |
| KR20250064439A (ko) * | 2023-11-02 | 2025-05-09 | 주식회사 삼양홀딩스 | 양이온성 지질 및 이의 제조방법 |
| CN117658839A (zh) * | 2023-11-22 | 2024-03-08 | 武汉大学 | 一种含羟基可电离脂质及其制备方法与应用 |
| WO2025124541A1 (zh) * | 2023-12-13 | 2025-06-19 | 上海瑞宏迪医药有限公司 | 一种阳离子脂质及其应用 |
| CN119798203A (zh) * | 2024-01-05 | 2025-04-11 | 仁景(苏州)生物科技有限公司 | 用于递送的脂质化合物和脂质纳米颗粒 |
| CN119874554B (zh) * | 2024-02-02 | 2025-08-19 | 仁景(苏州)生物科技有限公司 | 用于递送的脂质化合物和脂质纳米颗粒 |
| CN117695410B (zh) * | 2024-02-06 | 2024-05-03 | 中国人民解放军军事科学院军事医学研究院 | CRISPR/Cas9纳米抗菌剂及其制备方法 |
| CN119264001A (zh) * | 2024-04-03 | 2025-01-07 | 上海蓝鹊生物医药有限公司 | 含氮链状化合物、制备方法、包含其的组合物和应用 |
| CN118388360B (zh) * | 2024-04-17 | 2025-04-04 | 北京悦康科创医药科技股份有限公司 | 含有苯环结构的长效脾靶向阳离子脂质化合物、包含其的组合物及用途 |
| CN118852328A (zh) * | 2024-07-02 | 2024-10-29 | 北京大学 | 肽基可离子化脂质合成及其应用 |
| CN119019272A (zh) * | 2024-08-14 | 2024-11-26 | 中国药科大学 | 可电离脂质、包含其的组合物及其用途 |
| CN119039164B (zh) * | 2024-08-29 | 2025-04-11 | 国药中生生物技术研究院有限公司 | 可离子化脂质化合物、包含其的脂质纳米颗粒、药物组合物、药物制剂及其应用 |
| WO2026061393A1 (zh) * | 2024-09-18 | 2026-03-26 | 北京剂泰生命科技有限公司 | 递送编码分泌型蛋白的核酸分子的脂质纳米颗粒及其用途 |
| CN119661389A (zh) * | 2024-10-15 | 2025-03-21 | 山东大学 | 一种基于反式-1,4-环己烷二甲醇的可电离脂质、脂质纳米颗粒及其制备方法与应用 |
| CN121426694B (zh) * | 2025-12-31 | 2026-04-03 | 中国科学技术大学苏州高等研究院 | 脂质化合物或其药学上可接受的盐及其制备方法、脂质纳米颗粒和应用 |
| CN121426693B (zh) * | 2025-12-31 | 2026-04-03 | 中国科学技术大学苏州高等研究院 | 脂质化合物或其药学上可接受的盐及其制备方法、脂质纳米颗粒和应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4286012A3 (en) | 2015-09-17 | 2024-05-29 | ModernaTX, Inc. | Compounds and compositions for intracellular delivery of therapeutic agents |
| PL3350333T3 (pl) | 2015-09-17 | 2022-03-07 | Modernatx, Inc. | Polinukleotydy zawierające region stabilizujący ogon |
| AU2016336344A1 (en) | 2015-10-05 | 2018-04-19 | Modernatx, Inc. | Methods for therapeutic administration of messenger ribonucleic acid drugs |
| IL307179A (en) * | 2015-10-28 | 2023-11-01 | Acuitas Therapeutics Inc | Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids |
| HUE057877T2 (hu) | 2015-12-22 | 2022-06-28 | Modernatx Inc | Vegyületek és készítmények terápiás szerek intracelluláris bejuttatására |
| SMT202300097T1 (it) | 2017-03-15 | 2023-05-12 | Modernatx Inc | Composto e composizioni per il rilascio intracellulare di agenti terapeutici |
| US12077501B2 (en) | 2017-06-14 | 2024-09-03 | Modernatx, Inc. | Compounds and compositions for intracellular delivery of agents |
| WO2021055849A1 (en) | 2019-09-19 | 2021-03-25 | Modernatx, Inc. | Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents |
| AU2020350759A1 (en) * | 2019-09-19 | 2022-03-31 | Modernatx, Inc. | Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents |
| BR112022004936A2 (pt) | 2019-09-19 | 2022-06-14 | Modernatx Inc | Compostos lipídicos contendo carbonato e composições para distribuição intracelular de agentes terapêuticos |
-
2022
- 2022-12-07 AR ARP220103357A patent/AR127892A1/es unknown
- 2022-12-09 WO PCT/US2022/052347 patent/WO2023107669A1/en not_active Ceased
- 2022-12-09 US US18/716,220 patent/US20250144036A1/en active Pending
- 2022-12-09 JP JP2024534287A patent/JP2025502627A/ja active Pending
- 2022-12-09 EP EP22847452.4A patent/EP4444692A1/en active Pending
- 2022-12-09 CN CN202280081536.3A patent/CN118369308A/zh active Pending
- 2022-12-09 TW TW111147301A patent/TW202333708A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20250144036A1 (en) | 2025-05-08 |
| CN118369308A (zh) | 2024-07-19 |
| WO2023107669A1 (en) | 2023-06-15 |
| TW202333708A (zh) | 2023-09-01 |
| EP4444692A1 (en) | 2024-10-16 |
| JP2025502627A (ja) | 2025-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR127892A1 (es) | Compuestos y composiciones para la administración de agentes terapéuticos | |
| PE20250259A1 (es) | Compuestos de pirido[4,3-d] pirimidina | |
| PE20230238A1 (es) | Inhibidores de kras g12c | |
| AR120080A1 (es) | Compuestos lipídicos de cola ramificada y composiciones para la administración intracelular de agentes terapéuticos | |
| AR126351A1 (es) | Compuestos y sus sales inhibidores del inflamasoma nlrp3 | |
| PE20220931A1 (es) | Inhibidores de shp2 fosfatasa de tipo pirazolo[3,4-b]pirazina | |
| AR116114A1 (es) | Amidas heterocíclicas de entre 5 y 7 miembros como inhibidores de jak | |
| AR110139A1 (es) | COMPUESTOS MONO Y ESPIROCÍCLICOS QUE CONTIENEN CICLOBUTANO Y AZETIDINA COMO INHIBIDORES DE LA INTEGRINA aV | |
| AR120246A1 (es) | Aminas heteroaril-bifenilas para el tratamiento de las enfermedades por pd-l1 | |
| AR115646A1 (es) | Inhibidores de quinasas dependientes de ciclinas | |
| AR120773A1 (es) | Derivados de 3-(5-metoxi-1-oxoisoindolin-2-il)piperidin-2,6-diona como reductor de la actividad de la proteína wiz | |
| AR111808A1 (es) | Derivados de pirimidina como moduladores del receptor de pge2 | |
| AR093413A2 (es) | Antagonistas de neuroquinina, composiciones farmaceuticas que los comprenden, y uso de dichos antagonistas en la preparacion de un medicamento | |
| AR123648A1 (es) | Compuestos de carbamoilpiridona tricíclicos puenteados y sus usos | |
| AR123078A1 (es) | Medicamentos antiplaquetarios y usos de estos | |
| AR092279A1 (es) | Pirrol carboxamidas fluorometilo sustituidas | |
| AR123435A1 (es) | Derivados de sulfamoil urea que contienen resto alquilo-oxacicloalquilo, y usos de los mismos | |
| AR128285A1 (es) | Formulaciones farmacéuticas y métodos para el tratamiento de trastornos metabólicos y hepáticos | |
| AR116905A1 (es) | Derivados de ácido pirrolidino-2-carboxílico para tratar el dolor y afecciones relacionadas con el dolor | |
| AR124303A1 (es) | Inhibidores de irak4 | |
| AR127625A1 (es) | Degradadores bifuncionales inhibidores de la quinasa del progenitor hematopoyético y usos terapeuticos de los mismos | |
| AR119149A1 (es) | Derivados de isoquinolina como moduladores de la progranulina | |
| AR114167A1 (es) | Derivados de 2-ciclopropansulfonamidopirimidina como inhibidores de ctps1 | |
| JP2019522048A5 (https=) | ||
| AR128917A1 (es) | Inhibidores de malt-1 de tiazolo[5,4-b]piridina |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |